HighlightsComprehensive 585-page analysis of the French tumor marker testing market.Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next fiveyears.Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.Five-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories.Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.Current instrumentation technologies and feature comparison of leading analyzers.Sales and market shares of leading suppliers.Emerging diagnostic technologies and their potential market applications.Product development opportunities.Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Business opportunities and strategic recommendations for suppliers.Contains 585 pages and 95 tables Research Beam Model: Research Beam Product ID: 15677 3950 USD New
2014 Strategies for the French Tumor Marker Testing Market

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014 Strategies for the French Tumor Marker Testing Market

 
 
 

Highlights

  • Comprehensive 585-page analysis of the French tumor marker testing market.
  • Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Five-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 585 pages and 95 tables